Publication | Open Access
Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis
63
Citations
46
References
2022
Year
Glomerular DiseaseEngineeringRenal PathologyImmunologyRenal InflammationPathologySitu Inflammatory StatesNih AwardsSpatial OmicsInflammationGlomerulonephritisCell DevelopmentAcute Kidney InjuryChronic Kidney DiseaseMolecular ImagingRheumatoid ArthritisLupus ResearchAutoimmune DiseaseSystemic Lupus ErythematosusKidney FailureRenal FailureLupus NephritisComputational PathologyAutoimmunityRenal PathophysiologyDeep LearningMedical Image ComputingCell BiologyEnd-stage Renal DiseaseUrologyLupusBioimage AnalysisMedicineNephrologyKidney ResearchCell Detection
BACKGROUNDIn human lupus nephritis (LN), tubulointerstitial inflammation (TII) on biopsy predicts progression to end-stage renal disease (ESRD). However, only about half of patients with moderate-to-severe TII develop ESRD. We hypothesized that this heterogeneity in outcome reflects different underlying inflammatory states. Therefore, we interrogated renal biopsies from LN longitudinal and cross-sectional cohorts.METHODSData were acquired using conventional and highly multiplexed confocal microscopy. To accurately segment cells across whole biopsies, and to understand their spatial relationships, we developed computational pipelines by training and implementing several deep-learning models and other computer vision techniques.RESULTSHigh B cell densities were associated with protection from ESRD. In contrast, high densities of CD8+, γδ, and other CD4-CD8- T cells were associated with both acute renal failure and progression to ESRD. B cells were often organized into large periglomerular neighborhoods with Tfh cells, while CD4- T cells formed small neighborhoods in the tubulointerstitium, with frequency that predicted progression to ESRD.CONCLUSIONThese data reveal that specific in situ inflammatory states are associated with refractory and progressive renal disease.FUNDINGThis study was funded by the NIH Autoimmunity Centers of Excellence (AI082724), Department of Defense (LRI180083), Alliance for Lupus Research, and NIH awards (S10-OD025081, S10-RR021039, and P30-CA14599).
| Year | Citations | |
|---|---|---|
Page 1
Page 1